(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Japanese H3 rocket fails during launch of navigation satellite (video) - 2This St Nick Truly Can Advise How To Drink And Hack Your Headache
- 3The most effective method to Pick A Trade-in vehicle Stage
- 4Iranian missile hit on Ne'ot Hovav factory leads to fear of chemical leakage
- 5Energy security rifts widen in Europe
- Vietnam rethinks its flood strategy as climate change drives storms and devastation
- Hot peppers sent him to the ER. Two years later, a ‘ghost bill’ arrived.
- IDF begins destroying homes used by Hezbollah as forces move deeper into southern Lebanon
- Genesis Marks 10th Anniversary With Magma GT Concept Aimed at High-Performance Flagships
- Independence from the rat race for Recent college grads: Systems and Tips
- 6 Web-based Course Stages for Successful Learning and Educating
- The Quadrantid meteor shower peaks tonight, but will the full 'Wolf Moon' outshine the show?
- RFK Jr.’s vaccine advisers plan biggest change yet to childhood schedule
- Satellite data reveals a huge solar storm in 2024 shrank Earth's protective plasma shield
